Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jhep.2009.02.024
Title: Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: A 5-year follow-up
Authors: Aw, M.M. 
Dhawan, A.
Samyn, M.
Bargiota, A.
Mieli-Vergani, G.
Keywords: Autoimmune hepatitis
Autoimmune liver disease
Immunosuppression
Paediatrics
Sclerosing cholangitis
Issue Date: Jul-2009
Citation: Aw, M.M., Dhawan, A., Samyn, M., Bargiota, A., Mieli-Vergani, G. (2009-07). Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: A 5-year follow-up. Journal of Hepatology 51 (1) : 156-160. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jhep.2009.02.024
Abstract: Background/Aim: The aim of this study was to evaluate the outcome of mycophenolate mofetil (MMF) therapy in children with autoimmune liver disease who are resistant to or intolerant of standard immunosuppression. Methods: Inclusion criteria: (a) failure to achieve/maintain remission with prednisolone/azathioprine therapy or (b) significant treatment side-effects. Initial MMF dose was 20 mg/kg/day, gradually increased to a maximum of 40 mg/kg/day. Azathioprine was stopped when MMF was commenced. Results: Twenty-six children (17 female) were recruited. Median (range) age at diagnosis was 9.9 (1.2-14.4) years. Sixteen had Type 1 autoimmune hepatitis (AIH), two Type 2 AIH, and eight had autoimmune sclerosing cholangitis (ASC). Median (range) time from diagnosis to addition of MMF was 14.9 (0.2-108.6) months. Eighteen children responded to MMF, aspartate aminotransferase (AST) normalising in 14. At median (range) follow-up of 61.5 (19.5-96.3) months, AST remained normal in 12. All 18 children were well, but two had clinical signs of portal hypertension. Eight (6 ASC) did not respond: AST remained elevated in seven, one was listed for transplant for decompensated liver disease and one had clinical signs of portal hypertension. MMF was well tolerated. Leukopenia (n = 7) was the most common side-effect. Conclusions: MMF is an effective rescue therapy for children with AIH, but not for those with ASC. © 2009.
Source Title: Journal of Hepatology
URI: http://scholarbank.nus.edu.sg/handle/10635/107501
ISSN: 01688278
DOI: 10.1016/j.jhep.2009.02.024
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

90
checked on Mar 23, 2020

WEB OF SCIENCETM
Citations

78
checked on Mar 23, 2020

Page view(s)

89
checked on Mar 28, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.